Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/10567
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNayler, W Gen
dc.contributor.authorGu, X Hen
dc.date.accessioned2015-05-16T00:04:06Z
dc.date.available2015-05-16T00:04:06Z
dc.date.issued1991-08-01en
dc.identifier.citationJournal of Human Hypertension; 5 Suppl 1(): 55-9en
dc.identifier.govdoc1834847en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/10567en
dc.description.abstractAmlodipine is a 'second generation', long-acting calcium antagonist. To characterise the binding properties of this drug saturation binding studies were undertaken using (-)[3H]amlodipine and rat cardiac membrane fragments. (-)[3H]Amlodipine bound to a single population of high affinity binding sites with a KD of 1.64 +/- 0.17 nM, a Bmax of 0.45 +/- 0.08 pmol/mg protein and a Hill coefficient approaching unity. Binding was slow and required up to 5 hours to reach asymptote during incubation at 25 degrees C. The specific binding was totally inhibited by (-)amlodipine and (-)D600 and partially inhibited by (+)PN200-110, Bay K8644, (+)D600 and d-cis diltiazem. These results indicate that (-)[3H]amlodipine interacts strongly with the phenylalkylamine as well as the dihydropyridine binding sites. It also interacts with the benzothiazepine binding sites. The inhibition of (-)[3H]amlodipine binding by D600 is stereospecific, (-) greater than (+)D600. Bound (-)[3H]amlodipine dissociated slowly from its binding sites, less than 40% dissociation occurring during 5 hours of incubation (k-1 = 1.53 x 10(-3) min-1). These results indicate that the binding profile of amlodipine differs from that of other dihydropyridine-based Ca2+ antagonists. In addition they explain its slow onset of action, and slowed recovery on withdrawal.en
dc.language.isoenen
dc.subject.otherAmlodipineen
dc.subject.otherAnimalsen
dc.subject.otherBinding Sitesen
dc.subject.otherCalcium Channel Blockers.metabolism.pharmacologyen
dc.subject.otherDose-Response Relationship, Drugen
dc.subject.otherFemaleen
dc.subject.otherHydrogen-Ion Concentrationen
dc.subject.otherNifedipine.analogs & derivatives.antagonists & inhibitors.metabolismen
dc.subject.otherRatsen
dc.subject.otherRats, Inbred Strainsen
dc.subject.otherTime Factorsen
dc.titleThe unique binding properties of amlodipine: a long-acting calcium antagonist.en
dc.typeJournal Articleen
dc.identifier.journaltitleJournal of human hypertensionen
dc.identifier.affiliationDepartment of Medicine, University of Melbourne, Austin Hospital, Heidelberg, Victoria.en
dc.description.pages55-9en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/1834847en
dc.type.austinJournal Articleen
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairetypeJournal Article-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

14
checked on Mar 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.